Researchers test skin cancer drug for Alzheimer's treatment

09/12/2013 | KSNV-TV (Las Vegas)

A landmark study is being conducted in Las Vegas to determine the effect of bexarotene, an established skin cancer drug, on patients with Alzheimer's disease. The trial was initiated after the drug was linked to cognitive improvements in mice. Patients will undergo brain imaging to assess changes in their neurological condition.

View Full Article in:

KSNV-TV (Las Vegas)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY